Figure 4.
Bevacizumab treatment did not affect SKOV3 cell viability. Bevacizumab treatment (0, 1, 10, 100 and 1000 μg/ml) does not affect SKOV3 cell viability in 3D culture. There were no statistically significant difference (P > 0.05).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.